vs

Side-by-side financial comparison of Fulgent Genetics, Inc. (FLGT) and ServisFirst Bancshares, Inc. (SFBS). Click either name above to swap in a different company.

ServisFirst Bancshares, Inc. is the larger business by last-quarter revenue ($159.0M vs $71.1M, roughly 2.2× Fulgent Genetics, Inc.). Over the past eight quarters, ServisFirst Bancshares, Inc.'s revenue compounded faster (17.7% CAGR vs 0.1%).

Fulgent Genetics, Inc. is a molecular diagnostics technology firm that develops and offers genetic testing services including carrier screening, oncology testing, infectious disease detection, and hereditary condition analysis, serving clinical providers, pharma firms, research institutions and public health groups primarily in North America.

ServisFirst Bancshares, Inc. is a U.S.-based bank holding company operating full-service banking locations primarily across the Southeastern United States. It offers a full suite of commercial banking, consumer banking, wealth management, and mortgage lending services to small and medium-sized businesses, professional clients, and individual consumers.

FLGT vs SFBS — Head-to-Head

Bigger by revenue
SFBS
SFBS
2.2× larger
SFBS
$159.0M
$71.1M
FLGT
Faster 2-yr revenue CAGR
SFBS
SFBS
Annualised
SFBS
17.7%
0.1%
FLGT

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
FLGT
FLGT
SFBS
SFBS
Revenue
$71.1M
$159.0M
Net Profit
$83.0M
Gross Margin
30.2%
Operating Margin
21.1%
Net Margin
52.2%
Revenue YoY
-3.2%
Net Profit YoY
31.2%
EPS (diluted)
$0.04
$1.52

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FLGT
FLGT
SFBS
SFBS
Q1 26
$71.1M
$159.0M
Q4 25
$83.3M
$162.2M
Q3 25
$84.1M
$136.3M
Q2 25
$81.8M
$132.1M
Q1 25
$73.5M
$131.8M
Q4 24
$76.2M
$131.9M
Q3 24
$71.7M
$123.7M
Q2 24
$71.0M
$114.8M
Net Profit
FLGT
FLGT
SFBS
SFBS
Q1 26
$83.0M
Q4 25
$-23.4M
$86.4M
Q3 25
$-6.6M
$65.6M
Q2 25
$-19.0M
$61.4M
Q1 25
$-11.5M
$63.2M
Q4 24
$-5.9M
$65.2M
Q3 24
$-14.6M
$59.9M
Q2 24
$-8.7M
$52.1M
Gross Margin
FLGT
FLGT
SFBS
SFBS
Q1 26
30.2%
Q4 25
39.1%
Q3 25
42.2%
Q2 25
42.1%
Q1 25
38.6%
Q4 24
41.8%
Q3 24
37.3%
Q2 24
37.3%
Operating Margin
FLGT
FLGT
SFBS
SFBS
Q1 26
21.1%
Q4 25
-43.5%
66.3%
Q3 25
-18.3%
57.8%
Q2 25
-24.1%
58.0%
Q1 25
-26.9%
60.0%
Q4 24
-21.2%
60.2%
Q3 24
-23.8%
58.5%
Q2 24
-26.6%
58.0%
Net Margin
FLGT
FLGT
SFBS
SFBS
Q1 26
52.2%
Q4 25
-28.1%
59.0%
Q3 25
-7.9%
48.1%
Q2 25
-23.2%
46.5%
Q1 25
-15.7%
48.0%
Q4 24
-7.7%
52.9%
Q3 24
-20.4%
48.4%
Q2 24
-12.3%
45.4%
EPS (diluted)
FLGT
FLGT
SFBS
SFBS
Q1 26
$0.04
$1.52
Q4 25
$1.58
Q3 25
$1.20
Q2 25
$1.12
Q1 25
$1.16
Q4 24
$1.19
Q3 24
$1.10
Q2 24
$0.95

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FLGT
FLGT
SFBS
SFBS
Cash + ST InvestmentsLiquidity on hand
$23.4M
$1.8B
Total DebtLower is stronger
Stockholders' EquityBook value
$1.9B
Total Assets
$1.2B
$18.2B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FLGT
FLGT
SFBS
SFBS
Q1 26
$23.4M
$1.8B
Q4 25
$50.2M
Q3 25
$117.6M
Q2 25
$87.9M
Q1 25
$67.3M
Q4 24
$55.1M
Q3 24
$58.0M
Q2 24
$65.1M
Stockholders' Equity
FLGT
FLGT
SFBS
SFBS
Q1 26
$1.9B
Q4 25
$1.1B
$1.8B
Q3 25
$1.1B
$1.8B
Q2 25
$1.1B
$1.7B
Q1 25
$1.1B
$1.7B
Q4 24
$1.1B
$1.6B
Q3 24
$1.1B
$1.6B
Q2 24
$1.1B
$1.5B
Total Assets
FLGT
FLGT
SFBS
SFBS
Q1 26
$1.2B
$18.2B
Q4 25
$1.2B
$17.7B
Q3 25
$1.2B
$17.6B
Q2 25
$1.2B
$17.4B
Q1 25
$1.2B
$18.6B
Q4 24
$1.2B
$17.4B
Q3 24
$1.2B
$16.4B
Q2 24
$1.2B
$16.0B

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FLGT
FLGT

Segment breakdown not available.

SFBS
SFBS

Net Interest Income$148.1M93%
Noninterest Income$10.8M7%

Related Comparisons